The U.S. Market for Over-the-Counter Cough, Cold, Allergy, and Sinus Medications.

Jul 1, 2005
312 Pages - Pub ID: KLI1074786
Abstract Table of Contents Search Inside Report Buy By the Section Related Reports

This report on the U.S. market for over-the-counter (OTC) cough, cold, sinus and allergy (CCSA) medication presents an in-depth analysis of the performance of various CCSA drugs in the U.S. market. The analysis captures the performance of the market players, drug categories, and leading brands in terms of revenues and growth. It also identifies key issues, drivers, challenges, regulations, and trends affecting the marketplace.

In addition, the report provides a detailed analysis of consumer demographics and preferences in terms of dosage forms, brand names, and distribution/retail channels. Media spending by brand and various innovative promotional activities and marketing approaches are reviewed in detail, and extensive market share information is provided at both the marketer and branded product levels. New product launches in traditional and alternative therapy spheres are reviewed, and the impact of product messaging, packaging, and various other retail trends are discussed.

For the purposes of this study, the market for OTC CCSA products are segmented in the following main categories and subcategories.

  • Cold/Allergy/Sinus Medication
    • Antihistamines
    • Non-sedating antihistamine
    • Decongestants
  • Cough Medication
    • Antitussives
    • Expectorants
  • Combination Products
    • Cold/allergy/sinus medication
    • Cough medication
  • Other
    • Cold/allergy/sinus medication
    • Cough medication
  • Nasal products
    • Nasal aspirators
    • Nasal spray/drops/inhaler
    • Nasal strips
    • Mast cell stabilizers
  • Chest rubs

In addition, 11 top competitors are profiled in depth including product lines, product performance, product mix, and strategic approach.

Related Reports:

Rx to OTC Switches 2009
May 1, 2009 - KLI2196300 - $3,500.00

World Veterinary Health Products (Animal Pharmaceuticals, Vaccines, OTC and Performance Enhancers)
May 1, 2009 - KLI1829596 - $3,500.00

Healthcare in a Recession (OTC, Generics, Out of Pocket Spending, Healthcare Legislation, Retail Clinics, Outsourcing and Other Topics)
Apr 1, 2009 - KLI2123096 - $1,995.00

Smoking Cessation: World Markets
Nov 1, 2008 - KLI1646594 - $3,500.00

World OTC Pharmaceutical Markets: Self-Medication, Developing and Petro-Based Economies, BTC and Other Growth Trends
May 1, 2008 - KLI1614108 - $3,200.00

The Return of the Rx to OTC Switch: Market Analysis and Product Management Strategies
Apr 1, 2008 - KLI1692599 - $1,995.00

Vaccines: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry
Apr 1, 2008 - KLI1682234 - $4,100.00

Key Topics in Pharmaceutical Market Strategy 2008 (Drug Pricing, Rx to OTC switches, Retail Clinics, Prescribing Pharmacists, The Growing Out of Pocket Healthcare Market)
Mar 15, 2008 - KLI1689635 - $6,995.00

Anti-Infectives: World Market, 2nd. Ed., Vol. I: Antifungals
Mar 1, 2007 - KLI1399435 - $2,500.00

Vaccines: The World Market
Feb 1, 2007 - KLI1351010 - $3,995.00

800.298.5603
Int'l: +1.240.747.3096
Questions?
Contact a research specialist >
Most Popular Research
Outsourcing in Drug Discovery: The Contract Research (CRO) Market, 3rd Edition
Clinical Nutrition Products: World Market, 2nd. Edition
Clinical Nutrition Products: World Markets, 3rd Edition
Vaccines: World Market Analysis, Key Players, and Critical Trends in a Fast-Changing Industry
The Return of the Rx to OTC Switch: Market Analysis and Product Management Strategies
Prescription Dermatological Drugs: Worldwide Market, 6th Edition
Privacy Policy    |    Terms and Conditions    |    Site Map    |    Return Policy    |    Press    |    Help FAQs
Copyright © 2007 Kalorama Information. All Rights Reserved.
A division of Market Research Group, LLC
Trust-e Logo
Contact Us: 800.298.5603 (U.S.)
or +1.240.747.3096 (Int'l)
Hours: 7:00 a.m. to 7:00 p.m. EST Monday through Friday